In this issue we feature:
– Diagnosing and managing MI-VSD
– ESC QIs: Care and outcomes of adults with HF
– Clinical impact of CMR for CHD
– Palliative pharmacotherapy for CVD
– Periprocedural management and multidisciplinary care pathways: CIEDs
– Hereditary transthyretin amyloidosis
– Chronic heart failure
– Transthyretin amyloid cardiomyopathy
– Hypercholesterolaemia
– Half of Australians unaware of major CVD risk factor
– Schizophrenia: Cardiovascular risk assessment and management
– Team-based care to overcome therapeutic inertia in PAD
– COVID-19 resources
– Conferences, workshops and CPD